scispace - formally typeset
Open AccessJournal Article

Long-term survival.

Cho Yw, +1 more
- 01 Jan 1988 - 
- pp 277
TLDR
In transplants performed between 1971 and 1986, first cadaver donor grafts had a half-life ranging from 6.6 to 7.5 years in the period after the first year, and for patients receiving kidneys with no HLA-A,B mismatches, the average half- life was 10.1 years.
Abstract
1. In transplants performed between 1971 and 1986, first cadaver donor grafts had a half-life ranging from 6.6 to 7.5 years in the period after the first year. Second cadaver donor grafts had a half-life of 5.1 to 6.5 years. Parental donor grafts had a half-life of 9.3 to 11.8 years, whereas HLA identical sibling donor transplants had a half-life of 19.1 to 26.5 years. Siblings with no haplotype in common had an average half-life of 8.7 years. 2. Between 1971 and 1984, white recipients had an average half-life of 7.7 years, which increased to 9.3 years in 1985-1986. Black recipients' half-life decreased from 5.4 years in 1975-1976 to 3.5 years in 1985-1986. The reason for this decrease is not apparent. 3. The half-life of transplants of different recipient ages did not vary significantly. The average half-life during this period of study was 7.4 years for those younger than 21 years of age, 8.2 years for recipients 21 to 50 and 6.7 years for those older than 50. 4. In the early data, there was some evidence that the half-life of kidneys with cold ischemia below 13 hours was superior. However, in the latest period (between 1983 and 1986) the average half-life was 7.6 years for CIT below 13 hours, 7.2 years for those with 13 to 24 hours and 6.4 years for more than 24 hours. 5. For patients receiving kidneys with no HLA-A,B mismatches, the average half-life was 10.1 years. Those with A,B mismatches had a half-life of 6.7 years, and for those with no A,B antigens in common, the average half-life was 6 years. 6. In the period after 1981, the average half-life of patients with no A,B,DR mismatches was 9.1 years compared with 6.5 years for those with A,B,DR mismatches and 5.4 years for those with no A,B,DR antigens in common.

read more

Citations
More filters
Journal ArticleDOI

Resilience: a new integrative approach to health and mental health research

TL;DR: In this article, the authors put forth two definitions of resilience: sustainabilityability of purpose in the face of stress, and recovery from adversity, and encourage greater attention to aspects of biopsychosocial resourcefulness as a dimension of influence on health and mental health distinct from measures of risk found in standard models of public health inquiry.
Journal ArticleDOI

Opsoclonus myoclonus syndrome in neuroblastoma a report from a workshop on the dancing eyes syndrome at the advances in neuroblastoma meeting in Genoa, Italy, 2004

TL;DR: This paper summarizes the results obtained at the 2004 Advances in Neuroblastoma Research meeting, providing status of the art information on immune pathogenesis, clinical features, acute and chronic neurologic manifestations, current and novel therapeutic approaches.
Journal ArticleDOI

Evolution and current status of the Whipple procedure: an update for gastroenterologists.

TL;DR: Improved results of the Whipple procedure mean that large numbers of procedures are being performed at specialty centers, providing the opportunity to perform clinical trials, and that the procedure is used more widely, for instance, in benign diseases such as chronic pancreatitis.
Journal ArticleDOI

Occupational exposure to extremely low frequency electric and magnetic fields and Alzheimer disease: a meta-analysis

TL;DR: A systematic review and meta-analysis of published epidemiological studies on this subject was carried out in this paper, which revealed an association between occupational exposure to ELF-EMF and AD.
Journal ArticleDOI

Risk factors for late kidney allograft failure

TL;DR: Pre-transplant selection and preparation of the candidate as well as appropriate life style are recommended to improve life expectancy and extend graft survival.
Related Papers (5)
Trending Questions (1)
What is the biological half-life of the kidneys?

The biological half-life of kidneys varies based on donor type, recipient race, age, cold ischemia time, and HLA mismatches, ranging from 5.4 to 26.5 years in different scenarios.